Heart disease, cancer, and mental disease among the most costly conditions for women
Research Activities, September 2011
The cost of treating women for heart disease in 2008 was $43.6 billion, leading a list of the top 10 most expensive conditions for women, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. According to the analysis by the Federal agency, in 2008, the top 10 most costly conditions in terms of health care expenditures for women were:
- Heart disease.
- Mental disorders.
- Trauma-related disorders.
- Chronic obstructive pulmonary disease and asthma.
- Hypertension (high blood pressure).
- Back problems.
- Hyperlipidemia (high cholesterol levels).
Among the 10 costliest conditions:
- The second most costly disease to treat was cancer ($37.7 billion), followed by mental disorders ($37.3 billion), and trauma-related disorders ($34.1 billion).
- The lowest expenditures among the top 10 costliest conditions were for hyperlipidemia ($18.0 billion).
- The most common condition was high blood pressure (29.5 million).
- The least common condition was cancer (8.4 million).
The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey (MEPS), a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services, and how they are paid. For more information, go to Statistical Brief #331, Top 10 Most Costly Conditions among Men and Women, 2008: Estimates for the U.S. Civilian Noninstitutionalized Adult Population, Age 18 and Older.
For additional information, or to speak with an AHRQ data expert, please contact Linwood Norman at Linwood.Norman@ahrq.hhs.gov or call (301) 427-1248.
Current as of September 2011
Internet Citation: Heart disease, cancer, and mental disease among the most costly conditions for women: Research Activities, September 2011.
September 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/news/newsletters/research-activities/sep11/0911RA29.html